Related Experiment Video
Updated: Jun 22, 2025
08:02
In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells
Published on: September 23, 2021
2.5K
Engineering Versatile Bacteria-Derived Outer Membrane Vesicles: An Adaptable Platform for Advancing Cancer
Ziheng Luo1,2, Xiang Cheng1,2, Bin Feng1,2
1Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, 410013, China.
Summary
Bacteria-derived outer membrane vesicles (OMVs) offer a versatile platform for cancer immunotherapy. Engineering these vesicles enhances their potential as targeted cancer vaccines and adjuvants, paving the way for personalized treatments.
Area of Science:
- Biotechnology
- Immunology
- Oncology
Background:
- Cancer immunotherapy is shifting towards personalized and targeted strategies.
- Bacteria-derived outer membrane vesicles (OMVs) possess natural immunogenicity and engineering adaptability for therapeutic use.
Purpose of the Study:
- To provide a comprehensive overview of engineered OMVs for cancer immunotherapy.
- To explore state-of-the-art techniques in OMV engineering for enhanced immunogenicity and specificity.
Main Methods:
- Review of OMV biogenesis, composition, and intrinsic immunogenic properties.
- Exploration of genetic engineering and functional molecule incorporation for OMV modification.
- Analysis of rational design strategies for tailoring OMVs to specific cancer types.
Main Results:
- OMVs can be engineered to enhance immunogenicity and specificity for cancer treatment.
- Various methods exist for modifying OMVs, including genetic engineering and molecular incorporation.
- Clinical studies and challenges associated with OMV-based cancer vaccines and adjuvants are discussed.
Conclusions:
- Engineered OMVs represent a promising and adaptable platform for cancer immunotherapy.
- Rational design is crucial for optimizing OMVs as targeted cancer vaccines and adjuvants.
- Further research and clinical studies are needed to fully realize the potential of OMVs in cancer treatment.
Keywords:
bacterial engineeringcancer immunotherapyhybrid membrane vesiclesouter membrane vesiclessurface modificationMore Related Videos
Related Concept Videos
01:27Tumor Immunotherapy
510
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
510
01:30Cancer Vaccines
351
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
351